Top Stocks Where Cathie Wood Invested Heavily During Q2
10x Genomics, Inc., a leading biotechnology firm specialising in advanced genomic analysis solutions, has recently caught the attention of Cathie Wood's ARK Invest funds. The company, with the International Securities Identification Number (ISIN) US88025U1097, has a significant position in Wood's portfolio, valued at 735.2 million US dollars.
Based in the United States, 10x Genomics develops innovative platforms for spatial biology, single-cell analysis, and other genomic technologies that support scientific research and medical discoveries.
The company's Q2 2025 financial performance has been impressive, beating revenue estimates and demonstrating solid business momentum. As a result, the stock price fluctuated between around $12.29 to $13.24 per share in early August 2025. However, short-term volatility was observed after the earnings release on August 7, 2025. The company is listed on the Nasdaq exchange under the ticker symbol TXG.
The price of the company's shares on August 9, 2021, was 170.97 US dollars, although no recent share price data was available at the time of writing. In the second quarter of 2021, 337,000 shares were purchased.
Wood's ARK Invest funds tend to focus on disruptive, innovative technology companies with growth potential. The investment in 10x Genomics, Inc. reflects this strategy, as the company continues to make strides in the field of genomics.
For a more detailed analysis, including valuation and prospects, examining the full earnings call transcript or financial reports would be beneficial.
Other investors might be considering finance opportunities in 10x Genomics, given its strong performance and focus on cutting-edge genomic technologies. Given Cathie Wood's interest and ARK Invest's strategy of backing innovative firms, it is likely that investing in 10x Genomics could provide attractive returns in the future.
